tiprankstipranks
Advertisement
Advertisement

ALDX Stock Latest News

ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky
Class ActionALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky
1d ago
ALDX
Aldeyra Therapeutics Sued Over Alleged Misrepresentations About Key Drug Trial Data
PremiumClass Action
Aldeyra Therapeutics Sued Over Alleged Misrepresentations About Key Drug Trial Data
15d ago
ALDX
Aldeyra Repays Hercules Loan, Boosting Financial Flexibility
PremiumCompany Announcements
Aldeyra Repays Hercules Loan, Boosting Financial Flexibility
17d ago
8K
ALDX
Maintaining Hold on Aldeyra as FDA CRL Clouds Reproxalap’s Dry Eye Path and Lowers Approval Odds
PremiumRatings
Maintaining Hold on Aldeyra as FDA CRL Clouds Reproxalap’s Dry Eye Path and Lowers Approval Odds
1M ago
ALDX
Aldeyra downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Aldeyra downgraded to Neutral from Buy at H.C. Wainwright
1M ago
ALDX
Morning News Wrap-Up 3/17/26: Today’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up 3/17/26: Today’s Biggest Stock Market Stories!
1M ago
MA
MU
FDA issues Aldeyra CRL saying reproxalap NDA failed to demonstrate efficacy
Premium
The Fly
FDA issues Aldeyra CRL saying reproxalap NDA failed to demonstrate efficacy
1M ago
ALDX
How Did the FDA Shatter Investor Confidence In Aldeyra Therapeutics Stock (ALDX) Today?
Premium
Market News
How Did the FDA Shatter Investor Confidence In Aldeyra Therapeutics Stock (ALDX) Today?
1M ago
ALDX
FDA Issues Second Complete Response Letter for Reproxalap
PremiumCompany Announcements
FDA Issues Second Complete Response Letter for Reproxalap
1M ago
8K
ALDX
Aldeyra options imply 10.9% move in share price post-earnings
PremiumThe Fly
Aldeyra options imply 10.9% move in share price post-earnings
1M ago
ALDX
Aldeyra Therapeutics Announces Chief Development Officer Resignation
PremiumCompany Announcements
Aldeyra Therapeutics Announces Chief Development Officer Resignation
4M ago
8K
ALDX
Aldeyra Therapeutics: Buy Rating Affirmed Amid Promising Drug Development and Robust Investment Potential
PremiumRatings
Aldeyra Therapeutics: Buy Rating Affirmed Amid Promising Drug Development and Robust Investment Potential
4M ago
ALDX
Midday Fly By: Ford takes $19.5B EV writedown, Apple expanding iPhone lineup
PremiumThe FlyMidday Fly By: Ford takes $19.5B EV writedown, Apple expanding iPhone lineup
4M ago
F
F
Buy Rating for Aldeyra Therapeutics: Confidence in Reproxalap’s Approval and Financial Upside
Premium
Ratings
Buy Rating for Aldeyra Therapeutics: Confidence in Reproxalap’s Approval and Financial Upside
4M ago
ALDX
Unusually active option classes on open December 16th
Premium
The Fly
Unusually active option classes on open December 16th
4M ago
F
BP
Aldeyra Therapeutics Faces FDA PDUFA Date Extension
PremiumCompany Announcements
Aldeyra Therapeutics Faces FDA PDUFA Date Extension
4M ago
8K
ALDX
Aldeyra announces PDUFA extension for Reproxalap
PremiumThe Fly
Aldeyra announces PDUFA extension for Reproxalap
4M ago
ALDX
Aldeyra Therapeutics Completes Promising Phase 2 Trial for Alcohol-Associated Hepatitis
PremiumCompany Announcements
Aldeyra Therapeutics Completes Promising Phase 2 Trial for Alcohol-Associated Hepatitis
4M ago
ALDX
Aldeyra Therapeutics: Promising Advancements and Strategic Positioning Drive Buy Rating
PremiumRatings
Aldeyra Therapeutics: Promising Advancements and Strategic Positioning Drive Buy Rating
5M ago
ALDX
Promising Developments and Regulatory Progress Drive Buy Rating for Aldeyra Therapeutics
PremiumRatingsPromising Developments and Regulatory Progress Drive Buy Rating for Aldeyra Therapeutics
5M ago
ALDX
Aldeyra expands RASP platform
Premium
The Fly
Aldeyra expands RASP platform
5M ago
ALDX
Aldeyra Therapeutics Expands RASP Platform in 2025 Webcast
Premium
Company Announcements
Aldeyra Therapeutics Expands RASP Platform in 2025 Webcast
5M ago
8K
ALDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >